KraneShares MSCI All China Health Care Index ETF(KURE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KURE KraneShares MSCI All China Health Care Index ETF

未开盘 07-22 16:00:00 EDT

17.62

+0.12

+0.70%

盘后17.62

+0.00-0.01%

16:10 EDT

最高17.76	最低17.50	成交量2.43万
今开17.63	昨收17.50	日振幅1.48%
总市值9,162万	流通市值9,162万	总股本519.92万
成交额42.93万	换手率0.47%	流通股本519.92万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.6224,"timestamp":1784750400000,"preClose":17.5,"halted":0,"volume":24329,"hourTrading":{"tag":"盘后","latestPrice":17.62,"preClose":17.6224,"latestTime":"16:10 EDT","volume":7,"amount":123.3568,"timestamp":1784751004312,"change":-0.0024,"changeRate":-0.000136,"amplitude":0},"delay":0,"changeRate":0.006994285714285654,"floatShares":5199168,"shares":5199168,"eps":0,"marketStatus":"未开盘","change":0.1224,"latestTime":"07-22 16:00:00 EDT","open":17.63,"high":17.759,"low":17.5,"amount":429250,"amplitude":0.0148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784793600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.5,"sharesOutstanding":4750002,"nav":16.81,"aum":87404110.5,"dividendRate":0.040562,"bidAskSpread":0.003106,"preHourTrading":{"tag":"盘前","latestPrice":17.65,"preClose":17.5,"latestTime":"08:51 EDT","volume":72,"amount":1270.8,"timestamp":1784724674835,"change":0.15,"changeRate":0.008571,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.62,"preClose":17.6224,"latestTime":"16:10 EDT","volume":7,"amount":123.3568,"timestamp":1784751004312,"change":-0.0024,"changeRate":-0.000136,"amplitude":0},"volumeRatio":0.16134,"impliedVol":0.3887,"impliedVolPercentile":0.7371},"requestUrl":"/m/hq/s/KURE","defaultTab":"news","newsList":[{"id":"2653715567","title":"百济神州汪来：公司的背水一战，研发做了这些事","url":"https://stock-news.laohu8.com/highlight/detail?id=2653715567","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653715567?lang=zh_cn&edition=full","pubTime":"2026-07-23 12:05","pubTimestamp":1784779520,"startTime":"0","endTime":"0","summary":"从2010年成立至今，百济神州（ONC.US、06160.HK、688235.SH）已成为A股市值最高的药企，这背后离不开旗下一款重磅药物BTK抑制剂泽布替尼的开发成功，这也是公司当前的“利润奶牛”来源。7月22日，在首届大国新药全球会议（CPIC2026）上，百济神州总裁、全球研发负责人汪来回顾了公司如何背水一战投入换来泽布替尼成功故事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233818666284.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233818666284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","BK1500","BK1583","BK4139","LU1719994722.HKD","BK1161","BK0239","LU1969619763.USD","BK1588","LU2328871848.SGD","LU0588546209.SGD","KURE","LU1770034418.SGD","688235","ONC","BK4585","BK4526","06160","LU1251922891.USD","LU0307460666.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713988","title":"港股异动 | 康方生物(09926.HK)涨近6% 依沃西全球III期HARMONi 研究OS更新 东西方人群疗效高度一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653713988?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:38","pubTimestamp":1784777931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0348735423.USD","LU2476274308.USD","LU1961090484.USD","IE00BPRC5H50.USD","BK1574","LU0561508036.HKD","LU2488822045.USD","LU0348827113.USD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU0417516738.SGD","LU2399975544.HKD","LU0417516902.SGD","LU2476274720.SGD","LU0634319403.HKD","KURE","LU1720050803.USD","BK1161","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU0348766576.USD","09926","LU0540923850.HKD","LU0348784397.USD","LU1794554557.SGD","LU2778985437.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653189447","title":"覆盖65个品种 第12批国家药品集采7月31日开标","url":"https://stock-news.laohu8.com/highlight/detail?id=2653189447","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653189447?lang=zh_cn&edition=full","pubTime":"2026-07-23 10:46","pubTimestamp":1784774760,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯（记者丁爽）7月22日，国家组织药品联合采购办公室发布《第12批国家组织药品集中带量采购公告（第2号）》。根据集采公告，本次药品集中带量采购共涉及65个品种，包括万古霉素注射剂、环孢素口服常释剂型等，采购周期从中选结果执行之日算起，至2029年12月31日。此次集采收报价材料时间段为2026年7月31日上午7点30分至上午10点30分，当日开标，地址为上海市奉贤区南桥新城展园路398号。编辑 王进雨 校对 杨许丽","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/07/22/5744133838649502102.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/07/22/5744133838649502102.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1784732518129656.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1784732518129656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653890763","title":"石药集团在港交所公告称，SYS 6026注射液用于治疗HPV16或18型相关宫颈高级别鳞状上皮内病变的Ⅱ期临床试验在中国","url":"https://stock-news.laohu8.com/highlight/detail?id=2653890763","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653890763?lang=zh_cn&edition=full","pubTime":"2026-07-22 21:09","pubTimestamp":1784725775,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BZ08YS42.EUR","KURE","LU1226288253.USD","LU0072913022.USD","BK1191","LU2039709279.SGD","LU1993786604.SGD","LU1951186391.HKD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU1328277881.USD","LU1226287875.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU0501845795.SGD","LU1807302812.USD","LU1008478684.HKD","LU1152091168.USD","HK0000165453.HKD","BK1521","LU1960683339.HKD","LU0067412154.USD","LU0140636845.USD","IE0008369823.USD","LU1226287792.SGD","IE00B031HY20.USD","SG9999004220.SGD","BK1515","IE0008368742.USD","LU1226288170.HKD","LU0315179316.USD","LU1152091754.HKD","01093","IE00B543WZ88.USD","LU0880133367.SGD","LU1226287529.USD","LU1813983027.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653517317","title":"第12批国家药品集采将于7月31日开标","url":"https://stock-news.laohu8.com/highlight/detail?id=2653517317","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653517317?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:45","pubTimestamp":1784717137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653220610","title":"7月21日百济神州涨6.25%，创新药ETF银华基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653220610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653220610?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:35","pubTimestamp":1784622941,"startTime":"0","endTime":"0","summary":"证券之星消息，7月21日百济神州涨6.25%，收盘报275.5元，换手率6.82%，成交量7.84万手，成交额20.67亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共31家，其中持有数量最多的公募基金为银华基金的创新药ETF银华。创新药ETF银华目前规模为159.65亿元，最新净值0.871，较上一交易日上涨3.41%，近一年下跌0.9%。创新药ETF银华的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100030524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["KURE","BK1588","LU1969619763.USD","LU2328871848.SGD","LU1719994722.HKD","BK0239","06160","LU0307460666.USD","LU1251922891.USD","BK1583","LU1303224171.USD","LU1770034418.SGD","688235","BK1161","BK1500","LU0588546209.SGD","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179328618","title":"康方生物在新型Trop2/Nectin-4双特异性ADC（AK146D1）联合依沃西单抗治疗晚期非小细胞肺癌的II期研究中完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1179328618","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179328618?lang=zh_cn&edition=full","pubTime":"2026-07-20 13:33","pubTimestamp":1784525593,"startTime":"0","endTime":"0","summary":"康方生物宣布，其新型Trop2/Nectin-4双特异性抗体偶联药物（AK146D1）与依沃西单抗联合用于治疗晚期非小细胞肺癌的II期临床研究，已完成首例患者给药。这项研究旨在评估该联合疗法在此类患者中的安全性与初步疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU2488822045.USD","LU1961090484.USD","LU0417516902.SGD","IE00B543WZ88.USD","LU2476274308.USD","LU0540923850.HKD","09926","LU2476274720.SGD","LU1794554557.SGD","LU0348825331.USD","LU1720050803.USD","LU0348827113.USD","BK1574","LU0348784397.USD","LU0561508036.HKD","BK1161","LU0348783233.USD","KURE","LU0417516571.SGD","LU2778985437.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU2399975544.HKD","LU0348766576.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652269822","title":"创新药板块活跃 荣昌生物(09995)涨7.28% 多支头部公募大举举牌港股创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2652269822","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652269822?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:26","pubTimestamp":1784514372,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块活跃，荣昌生物 涨7.28%，歌礼制药-B涨6.81%，科伦博泰生物涨6.70%，康诺亚-B涨6.25%，康方生物涨5.83%，药明合联涨5.53%，石药集团涨4.94%，三生制药涨5.02%，信达生物涨4.55%，药明生物涨4.60%，恒瑞医药涨4.00%，百济神州涨3.88%。头部机构密集触及举牌线，凸显对创新药板块的看好。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986240","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","LU0516422366.SGD","LU0348735423.USD","HK0000165453.HKD","LU0043850808.USD","06160","LU0359201612.USD","01093","LU0979878070.USD","LU2097828474.EUR","BK1593","IBBQ","LU0052750758.USD","09995","KURE","LU1226288170.HKD","LU0348827113.USD","LU0516422440.USD","LU0708995583.HKD","BK4585","06978","01530","01276","BK1576","LU0417516738.SGD","LU0516423174.USD","09926","MEDX","BK1588","LU1720050803.USD","02269","LU1951186391.HKD","SG9999002463.SGD","01672","BK0239","688331","IE00BZ08YT58.USD","LU0327786744.USD","LU2328871848.SGD","KCAI","VXUS","LU1064130708.USD","01801","02268","LU0196878994.USD","LU1242518857.USD","02162","159992","06990","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652375562","title":"每周股票复盘：百济神州（688235）将召开2026Q2业绩电话会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652375562","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652375562?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:06","pubTimestamp":1784394370,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，百济神州报收于250.51元，较上周的267.84元下跌6.47%。本周，百济神州7月15日盘中最高价报285.85元。百济神州当前最新总市值3861.41亿元，在化学制药板块市值排名1/149，在两市A股市值排名34/5199。本周关注点公司公告汇总：百济神州将于2026年8月5日召开第二季度业绩电话会议公司公告汇总百济神州有限公司将于2026年8月5日发布截至2026年6月30日止第二季度未经审计财务业绩及2026年半年度主要财务数据公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1770034418.SGD","LU2328871848.SGD","BK0239","BK1161","BK1500","LU0307460666.USD","06160","BK1588","LU1251922891.USD","688235","LU1719994722.HKD","BK1583","KURE","LU0588546209.SGD","LU1303224171.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652340785","title":"睿远基金旗下产品最新重仓股曝光：傅鹏博首次建仓炬光科技，赵枫买回药明生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2652340785","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652340785?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:22","pubTimestamp":1784283720,"startTime":"0","endTime":"0","summary":"7月17日，睿远基金旗下两位明星基金经理的在管产品披露了2026年二季报，其最新前十大重仓股也随之浮出水面。在2026年二季度期间，由傅鹏博和朱璘管理的睿远成长价值混合基金，港股仓位已降至历史最低水平。调仓换股方面，该基金首次建仓炬光科技，并大举减持中际旭创、东山精密。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607173811162060.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607173811162060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0819121731.USD","LU0823426480.USD","LU0979878070.USD","LU0417516902.SGD","LU0456827905.SGD","688167","BK1521","SG9999002463.SGD","LU0348825331.USD","BK1576","LU0326950275.SGD","LU0588546209.SGD","LU0348735423.USD","LU0359201612.USD","LU0181495838.USD","LU0039217434.USD","LU0051755006.USD","LU1242518857.USD","LU0140636845.USD","LU0856984785.SGD","BK1610","IE00B0JY6N72.USD","LU1794554557.SGD","LU0516423091.SGD","LU0327786744.USD","02269","BK1589","LU2039709279.SGD","LU0417516738.SGD","BK0214","LU1880383366.USD","LU0516422440.USD","SG9999002562.SGD","LU0516423174.USD","LU0823426308.USD","LU0043850808.USD","LU3063872942.SGD","LU0708995583.HKD","LU0052750758.USD","LU0307460666.USD","LU0516422952.EUR","LU0359202008.SGD","LU0572944931.SGD","LU1242518931.SGD","LU1688375341.USD","BK1141","LU0320764599.SGD","LU1720050803.USD","KURE","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134893755","title":"石药集团产品获准用于成人不可切除或转移性HER2阳性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1134893755","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134893755?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:51","pubTimestamp":1784278315,"startTime":"0","endTime":"0","summary":"石药集团的一款产品已获批准，用于治疗成人不可切除或转移性HER2阳性乳腺癌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287875.USD","LU0315179316.USD","LU0072913022.USD","LU1960683339.HKD","LU1951186391.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU1008478684.HKD","KURE","LU0067412154.USD","IE00BZ08YS42.EUR","LU1226287529.USD","BK1521","BK1191","LU0314109678.HKD","BK1515","LU1152091754.HKD","IE00B031HY20.USD","LU1226287792.SGD","01093","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1152091168.USD","LU0140636845.USD","LU1226288170.HKD","LU0326950275.SGD","HK0000165453.HKD","LU0880133367.SGD","LU1328277881.USD","IE0008368742.USD","LU2039709279.SGD","LU1993786604.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","LU1813983027.USD","LU1226288253.USD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652405197","title":"7月17日百济神州跌7.81%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652405197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652405197?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:25","pubTimestamp":1784276712,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日百济神州跌7.81%，收盘报250.51元，换手率6.62%，成交量7.62万手，成交额19.33亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1251922891.USD","LU1969619763.USD","BK0239","688235","BK1161","LU1719994722.HKD","LU0307460666.USD","LU0588546209.SGD","LU1303224171.USD","KURE","LU1770034418.SGD","BK1588","BK1583","LU2328871848.SGD","06160","BK1500","160916"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476043","title":"港股医药股走低，昭衍新药跌近11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652476043?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:36","pubTimestamp":1784255767,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449591","title":"石药集团(01093)：注射用西罗莫司(白蛋白结合型)用于治疗上皮样血管内皮瘤的II期临床试验在中国首家中心正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449591","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651449591?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:29","pubTimestamp":1784201342,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团自主开发的注射用西罗莫司用于治疗进展性或症状性上皮样血管内皮瘤患者的II期临床试验已在中国首家中心正式启动。该临床试验为多中心、开放性、非随机的II期临床试验，拟纳入经组织学确诊的不适合进行根治性手术，且经研究者评估需要接受系统性全身治疗的进展性或症状性上皮样血管内皮瘤患者，旨在评估该产品用于进展性或症状性上皮样血管内皮瘤患者中的有效性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","LU1807302812.USD","IE0008368742.USD","IBBQ","LU0067412154.USD","LU2039709279.SGD","LU1993786604.SGD","LU1226287875.USD","BK1191","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1226288253.USD","LU0072913022.USD","01093","LU1152091754.HKD","KURE","LU0314109678.HKD","LU1008478684.HKD","LU1328277881.USD","IE0008369823.USD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","BK1515","LU1226287792.SGD","LU1226287529.USD","LU1226288170.HKD","IE00BZ08YT58.USD","BK1521","IE00BZ08YR35.GBP","HK0000165453.HKD","LU1813983027.USD","IE00B543WZ88.USD","LU1152091168.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU0140636845.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651449895","title":"石药集团(01093)：SYS 6043用于治疗铂耐药晚期卵巢癌、原发性腹膜癌以及输卵管癌的Ⅲ期临床试验在中国首家中心正式启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2651449895","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651449895?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:27","pubTimestamp":1784201245,"startTime":"0","endTime":"0","summary":"集团于2026年7月收到中国国家药品监督管理局签发的药物临床试验批准通知书，获批后启动一项评价该产品对比研究者选择的化疗用于铂耐药晚期卵巢癌、原发性腹膜癌以及输卵管癌参与者的随机、多中心、开放标签、阳性对照的Ⅲ期临床试验。该Ⅲ期临床试验旨在评价该产品与研究者选择的化疗方案，在治疗铂耐药晚期卵巢癌、原发性腹膜癌以及输卵管癌参与者中的临床有效性和安全性。目前，受试者招募和筛选工作正在积极推进中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","LU1813983027.USD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU1328277881.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","SG9999004220.SGD","IBBQ","IE00B543WZ88.USD","LU1008478684.HKD","BK1515","IE00BZ08YR35.GBP","LU1951186391.HKD","LU1226287529.USD","LU0072913022.USD","LU0140636845.USD","01093","LU1152091754.HKD","LU1807302812.USD","LU0326950275.SGD","LU0880133367.SGD","BMED","LU1226288170.HKD","BK1521","LU0501845795.SGD","LU1226287792.SGD","LU0315179316.USD","LU1226287875.USD","IE00B5MMRT66.SGD","LU2039709279.SGD","BK1191","LU1960683339.HKD","KURE","LU0067412154.USD","LU1993786604.SGD","LU0314109678.HKD","IE0008368742.USD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651814445","title":"第12批国采报量即将结束，这些常用药如何通过集采实现降价？","url":"https://stock-news.laohu8.com/highlight/detail?id=2651814445","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651814445?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:09","pubTimestamp":1784196540,"startTime":"0","endTime":"0","summary":"7月16日下午，第12批国家组织药品集中带量采购医药机构报量工作将结束。国家医保局发布提示称，截至当日中午12时，共有4.5万家医药机构填报采购需求量，涉及65个采购品种、530多家医药企业。第11批集采纳入的乙磺酸尼达尼布软胶囊，主要用于治疗特发性肺纤维化，集采前患者每月用药费用高达7000多元，集采后每月费用降至几百元。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2026/07/16/5741883645346521978.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/07/16/5741883645346521978.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1784196026129615.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1784196026129615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651164084","title":"大行评级｜里昂：上调信达生物目标价至139.9港元，维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2651164084","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651164084?lang=zh_cn&edition=full","pubTime":"2026-07-16 14:11","pubTimestamp":1784182307,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2488822045.USD","LU0455707207.USD","LU0502904849.HKD","BK1589","LU2097828805.USD","LU2097828631.EUR","LU2097828714.EUR","KURE","01801","LU2097828474.EUR","LU2097828557.USD","LU2242644610.SGD","LU2328871848.SGD","HK0000165453.HKD","LU1969619763.USD","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651945934","title":"港股概念追踪 | 实验猴身价飙升至20万！多家企业反映供不应求 CRO行业订单全面回暖(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651945934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651945934?lang=zh_cn&edition=full","pubTime":"2026-07-16 07:49","pubTimestamp":1784159344,"startTime":"0","endTime":"0","summary":"当前，整个CRO行业正处于订单全面回暖的上行期。药明康德、康龙化成、益诺思、昭衍新药等多家头部CRO企业2026年一季度新签订单普遍实现大幅增长。截至一季度末，在手订单约31亿元，同比增长40.9%。对于2026年，药明康德此前预计，2026全年整体收入达513亿元至530亿元；持续经营业务收入同比增长18%至22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","SG9999002562.SGD","KCAI","06127","LU0348825331.USD","LU1794554557.SGD","SG9999002463.SGD","BK1576","BK1589","LU0979878070.USD","LU1046422090.SGD","03759","BK1141","LU0359202008.SGD","IE00B0JY6N72.USD","BK4588","LU0326950275.SGD","LU2045819591.USD","LU0516422952.EUR","LU0348767384.USD","LU0140636845.USD","BK1583","LU0039217434.USD","BK1521","LU3063872942.SGD","LU0348766576.USD","LU1720050803.USD","LU1880383366.USD","02359","LU0043850808.USD","LU0456846285.SGD","LU0359201612.USD","LU0181495838.USD","LU0708995583.HKD","LU0823426480.USD","LU0052750758.USD","LU0307460666.USD","LU0819121731.USD","LU0516423174.USD","KURE","LU0456827905.SGD","BK1610","LU0417516902.SGD","LU0823426308.USD","LU0572944931.SGD","02269","LU0320764599.SGD","LU0856984785.SGD","LU0516422366.SGD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651810439","title":"港股早盘高开高走 恒指半日涨1.46% 创新药、猪肉概念强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2651810439","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651810439?lang=zh_cn&edition=full","pubTime":"2026-07-15 12:11","pubTimestamp":1784088667,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘高开高走，三大股指均升逾1%。截至午间收盘，恒生指数上涨1.46%；国企指数涨1.16%；恒生科技指数涨1.39%。猪价底部大概率已现，预计周期临近上行。预计2026年半年度归属于上市公司股东的扣除非经常性损益的净利润约为人民币20.00亿元到人民币26.00亿元，与上年同期相比，将增加人民币18.62亿元到人民币24.62亿元，同比增长1349%到1784%。MiniMax盘中反复拉升，午间收涨14.96%。港股将受益于中国内地强劲而有韧性的经济表现，建议超配H股。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YWY0NWM4YTUxZGFlZmZjNmE5MDYxNjI4NjU1Mjc3NzM1Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985921","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2045819591.USD","LU1282651121.HKD","LU1211504680.USD","LU0039217434.USD","02800","01801","07500","SG9999003461.SGD","LU1023057109.AUD","LU2039709279.SGD","BK1562","LU0871576103.HKD","LU1152091754.HKD","BK1521","LU0405327494.USD","LU0561508036.HKD","BK1583","BK1610","LU0287142896.SGD","SG9999002562.SGD","SG9999006597.SGD","02833","LU1008478684.HKD","02269","LU2399975544.HKD","LU0320764599.SGD","IE00BZ08YS42.EUR","LU0211977185.USD","LU0169518387.USD","LU3063872942.SGD","LU0043850808.USD","LU1328277881.USD","LU1497734951.SGD","LU0293314216.USD","LU0862451753.SGD","01177","LU0048597586.USD","LU0979878070.USD","LU0469268626.HKD","LU0972618739.USD","LU0348827113.USD","06869","LU0315178854.USD","LU0327786744.USD","LU0651947912.USD","LU0821914370.USD","KURE","00857","LU0456846285.SGD","688981","LU0572944931.SGD","LU1051768304.USD","BK1523","BK1607","LU0865486749.SGD","LU0588545490.SGD","82800","IE0008369823.USD","LU0140636845.USD","LU1522347837.USD","LU2476274308.USD","LU1226288253.USD","LU0067412154.USD","LU0314109678.HKD","LU0228367735.SGD","LU0611395673.USD","LU0675040207.SGD","LU1226287875.USD","BK1550","LU1675838814.USD","07200","BK1589","LU1813983027.USD","LU1993786604.SGD","LU2242644610.SGD","LU2488822045.USD","00981","LU1831875114.USD","002714","SBHMY","SG9999012710.SGD","LU0516423174.USD","LU0348805143.USD","LU0890818403.SGD","LU0348825331.USD","LU0516422440.USD","LU1051769294.HKD","LU0072462343.USD","LU1188198961.HKD","LU1224444064.USD","LU1794554557.SGD","BK1117","LU0856984785.SGD","SG9999001226.SGD","83115","BK1163","BK1584","IE00B031HY20.USD","LU0708995583.HKD","HHImain","LU0501845795.SGD","LU1720050803.USD","03115","LU1046422090.SGD","LU0819121731.USD","IE0032431581.USD","LU1634259391.SGD","BK1161","BK1172","BK1549","600028","IE00B19Z5X02.USD","LU1880383366.USD","SGXZ86797644.SGD","06990","LU2097828474.EUR","LU2328871848.SGD","BK1528","LU2778985437.USD","SG9999002463.SGD","SG9999014674.SGD","LU0326950275.SGD","LU0307460666.USD","SCHYY","BK1184","601869","09115","LU0823426308.USD","LU1961090484.USD","BK1237","LU0634319403.HKD","LU1226287792.SGD","LU0651946864.USD","LU0051755006.USD","LU0072913022.USD","LU0348783233.USD","02419","LU1251922891.USD","LU0359201612.USD","LU0417516571.SGD","LU0502904849.HKD","LU1497733557.USD","LU0463099449.HKD","603259","HSI","LU1785774172.SGD","IE00B543WZ88.USD","IE0008368742.USD","LU2097828714.EUR","LU1115378108.SGD","BK1191","LU0823426480.USD","BK1506","SG9999004220.SGD","LU0359202008.SGD","LU0441854154.USD","IE00B5MMRT66.SGD","02628","03037","LU2097828631.EUR","LU1969619763.USD","07300","SG9999012736.USD","LU0455707207.USD","LU0052750758.USD","BK1603","LU0456827905.SGD","LU0588545730.USD","LU1303224171.USD","LU0348767384.USD","LU1951186391.HKD","LU0348784397.USD","LU0828237940.HKD","LU0244354667.USD","LU0880133367.SGD","LU1048588211.SGD","01093","LU1515016050.SGD","BK1576","LU1808992512.USD","02714","09926","LU1960683339.HKD","SG9999012728.SGD","03419","IE00BZ08YT58.USD","LU0315179316.USD","LU1048596156.SGD","LU0251144936.SGD","LU1152091168.USD","LU0531971595.HKD","00386","LU0164865239.USD","LU0196878994.USD","IE00BZ08YR35.GBP","LU0540923850.HKD","BK1614","LU1719994722.HKD","01477","LU0405327148.USD","LU1226288170.HKD","HSTECH","BK1149","LU0588545904.SGD","LU0163747925.USD","LU0348766576.USD","LU0417516902.SGD","LU1688375341.USD","LU2293587155.HKD","601857","IE00BQJZWZ67.USD","601628","LU0181495838.USD","02268","SG9999012744.USD","SG9999001093.SGD","01610","LU1497733631.SGD","513600","LU1634259557.SGD","LU0417516738.SGD","LU0516422366.SGD","01928","HK0000286598.CNH","LU0588546209.SGD","LU2476274720.SGD","WXXWY","02359","00100","BK1226","IE00B0JY6N72.USD","IE00BWDBJ730.SGD","BK1515","LU0359201885.HKD","LU0516422952.EUR","SGXZ62798434.SGD","LU2257852520.SGD","LU0348783662.USD","LU1242518931.SGD","MCHmain","BK1574","LU1770034418.SGD","LU0348735423.USD","LU1807302812.USD","LU0173614495.USD","BK1526","IE00BPRC5H50.USD","LU2097828805.USD","LU1226287529.USD","LU2097828557.USD","BK1141","LU0516423091.SGD","LU2125910500.SGD","HK0000165453.HKD","LU1282651048.USD","LU0862451837.USD","LU0640798160.USD","LU1242518857.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651291435","title":"创新药概念全线扬升 科伦博泰生物(06990)涨逾11% 机构指创新药企迎业绩兑现窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2651291435","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651291435?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:07","pubTimestamp":1784084836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念盘中全线扬升，截至发稿，欧康维视生物-B 涨13.35%，科伦博泰生物涨11.20%，康方生物涨8.82%，信达生物涨8.72%，三生制药涨8.11%，康诺亚-B涨7.62%，药明合联涨7.52%，荣昌生物涨7.09%，乐普生物涨6.87%，亚盛医药涨6.26%。该机构持续看好国内创新药出海β向上可持续性，提示投资者关注2027年起众多前期已达成BD的分子将在海外开启商业化新周期所带来的投资机会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985914","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU2399975544.HKD","BK1587","LU2778985437.USD","LU2476274308.USD","KURE","LU0417516902.SGD","BK1191","09995","09926","01477","IE00B543WZ88.USD","BK1583","LU0561508036.HKD","LU0417516571.SGD","01530","06855","02157","LU2097828805.USD","BK1574","BK1141","LU2097828557.USD","LU0455707207.USD","01801","IBBQ","BK1161","06990","06978","LU0634319403.HKD","MEDX","02162","LU0348784397.USD","BK1593","LU0348767384.USD","IE00BPRC5H50.USD","LU2097828631.EUR","159992","LU0540923850.HKD","LU0348825331.USD","BK1589","LU1961090484.USD","02268","LU0348827113.USD","SG9999014674.SGD","LU2097828714.EUR","LU2488822045.USD","LU2097828474.EUR","LU0502904849.HKD","LU2328871848.SGD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://kraneshares.com/kure/","stockEarnings":[{"period":"1week","weight":-0.0159},{"period":"1month","weight":0.1851},{"period":"3month","weight":0.0336},{"period":"6month","weight":-0.037},{"period":"1year","weight":-0.0696},{"period":"ytd","weight":0.0342}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.011813},{"month":2,"riseRate":0.625,"avgChangeRate":0.040467},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.011251},{"month":4,"riseRate":0.555556,"avgChangeRate":0.009997},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.006548},{"month":6,"riseRate":0.555556,"avgChangeRate":0.020849},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025079},{"month":8,"riseRate":0.5,"avgChangeRate":-0.022203},{"month":9,"riseRate":0.5,"avgChangeRate":0.002438},{"month":10,"riseRate":0.5,"avgChangeRate":-0.020874},{"month":11,"riseRate":0.5,"avgChangeRate":0.01787},{"month":12,"riseRate":0.375,"avgChangeRate":-0.04543}],"exchange":"ARCA","name":"KraneShares MSCI All China Health Care Index ETF","nameEN":"KraneShares MSCI All China Health Care Index ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"KraneShares MSCI All China Health Care Index ETF(KURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供KraneShares MSCI All China Health Care Index ETF(KURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"KraneShares MSCI All China Health Care Index ETF,KURE,KraneShares MSCI All China Health Care Index ETF股票,KraneShares MSCI All China Health Care Index ETF股票老虎,KraneShares MSCI All China Health Care Index ETF股票老虎国际,KraneShares MSCI All China Health Care Index ETF行情,KraneShares MSCI All China Health Care Index ETF股票行情,KraneShares MSCI All China Health Care Index ETF股价,KraneShares MSCI All China Health Care Index ETF股市,KraneShares MSCI All China Health Care Index ETF股票价格,KraneShares MSCI All China Health Care Index ETF股票交易,KraneShares MSCI All China Health Care Index ETF股票购买,KraneShares MSCI All China Health Care Index ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KraneShares MSCI All China Health Care Index ETF(KURE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供KraneShares MSCI All China Health Care Index ETF(KURE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}